Protocol Review & Monitoring Committee

The University of Colorado Cancer Center Clinical Investigations Core's Protocol Review & Monitoring Committee (PRMC) ensures that all clinical trials conducted at UCCC are:

  • scientifically sound
  • appropriately designed
  • feasible for completion
  • compliant with federal clinical trial guidelines
  • concordant with UCCC goals, interests and responsibilities

The PRMC also reviews investigator-initiated studies and offers meaningful feedback to PIs about trial design, biostatistical aspects of the study, practical considerations of data management and overall feasibility.

 

Protocol Review & Monitoring Committee

Location

Anschutz Medical Campus
Anschutz Cancer Pavilion, Suite 3200
720-848-0018

Leadership & Staff

Brian Kavanagh, MD, MPH
Committee Chair
brian.kavanagh@ucdenver.edu
720-848-0156

Madeleine Kane, MD, PhD
Medical Director
madeleine.kane@ucdenver.edu
720-848-0354

Gloria Ochoa, BA, BIS
Manager
gloria.ochoa@ucdenver.edu
720-848-0650

Jennifer Maitlen
Regulatory Affairs Manager
jennifer.maitlen@ucdenver.edu

Donna Wilber
HR/Finance Manager
donna.wilber@ucdenver.edu

2008 PRMC Meetings

1 to 3 pm

January 9 & 23
February 13 & 27
March 12 & 26
April 9 & 23
May 14 & 28
June 11 & 25
July 9 & 23
August 13 & 27
September 10 & 24
October 8 & 22
November 12 & TBD
December 10 & TBD